NUVB
Nuvation Bio Inc. (NUVB) reported revenue of $62.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $62.90M | +699.0% |
| FY 2024 | $7.87M | - |
| FY 2023 | $0.00 | - |
Nuvation Bio Inc. (NUVB) reported revenue of $62.90M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.